Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 123   

Articles published

4502 6,123.00 +15.00 (0.25%)
price chart
Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk
Lilly, which co-promoted Actos from 1999 to 2006, was not immediately available to comment. The company has previously said it will be indemnified by Takeda for its losses and expenses from the litigation based on the terms of its agreement with Takeda.
Takeda, Lilly Lose Bid to Overturn $9 Billion Actos Award  Bloomberg
Takeda Announces Completion of the Post-Marketing Commitment to Submit ...  MarketWatch
Related articles »  
BioMotiv and Takeda Pharmaceutical Company Enter into Strategic Partnership
CLEVELAND & OSAKA, Japan, Sep 25, 2014 (BUSINESS WIRE) -- Takeda Pharmaceutical Company Limited (�Takeda�) and BioMotiv, LLC, the therapeutic accelerator company associated with The Harrington Project for Discovery & Development, jointly ...
Related articles »  
Takeda Pharma: Phase 3 Ixazomib Trial Meets Primary Endpoint - Quick Facts
(RTTNews.com) - Takeda Pharmaceutical Company Limited (TKPYY.PK, TKPHF.PK) announced that the randomized, double-blind, placebo-controlled TOURMALINE-MM1 pivotal Phase 3 trial evaluating the safety and efficacy of ixazomib, the first oral ...
Interim results positive for Takeda blood cancer med  Seeking Alpha (registration)
Company : Takeda Pharmaceutical Company Limited  Business Wire India (press release)
Takeda's ixazomib a Breakthrough Therapy for amyloidosis
The FDA designates Takeda Pharmaceutical Company's (OTCPK:TKPHF) (OTCPK:TKPYY) investigational oral proteasome inhibitor, ixazomib, a Breakthrough Therapy for the treatment of relapsed or refractory systemic light-chain (AL) amyloidosis.
Takeda: FDA Grants Breakthrough Therapy Status To Ixazomib  Nasdaq
Takeda's Investigational, Oral Proteasome Inhibitor Ixazomib Granted ...  Business Wire India (press release)
Related articles »  
Penny Stocks in Queue : Takeda Pharmaceutical (TKPYY), Lenovo Group ...
Las Vegas, NV - Feb 12, 2015 - (Techsonian) - Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPYY) holds in the research, development, manufacturing, marketing, sale, and import/export of pharmaceutical drugs worldwide.
Penny Stock's Buzzers: Amcor Limited (AMCRY), Takeda Pharmaceutical Co ...
Coinciding with World Environment Day, global packaging leader Amcor Limited (ADR) (OTCMKTS:AMCRY) declares it is partnering with the Earthwatch Institute for the fourteenth successive year, to offer co-workers the opportunity to participate in ...
More Japanese pharma companies expanding R&D operations in Singapore
Takeda Pharmaceutical first established its Asia-Pacific regional operations and clinical development hub in Singapore in 2008.
Takeda Regroups Singapore Operations in New, Expanded Office  The FINANCIAL
BRIEF-Takeda says to buy select portfolio from Turkey's Neutec
Feb 24 (Reuters) - Japan's Takeda Pharmaceutical Co Ltd : * Says to buy select portfolio from Neutec to enhance its business in Turkey.
Novartis blood cancer drug wins US OK after setback
Farydak was approved for use in combination with Takeda Pharmaceutical Co Ltd's Velcade and the anti-inflammatory drug dexamethasone once a patient has received at least two prior treatment regimens.
Takeda to obtain select portfolio from Neutec to enhance its business in Turkey
Takeda Pharmaceutical Company Limited and NEUTEC ILA� SANAYI VE TICARET A.S Neutec�) announced that Takeda's wholly -owned subsidiary, Takeda GmbH , and Neutec have signed an agreement to obtain a select portfolio from Neutec, composed ...
Takeda grows in Turkey with Neutec subsidiary acquisition  PMLiVE
Takeda Acquires Select Portfolio from Neutec to Boost Business in Turkey  Drug Discovery & Development